SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with a favourable outcome.

Agustina Maria LascanoJ-B EpineyM CoenJ SerratriceRaphael Bernard-ValnetP H LaliveThierry KuntzerA Hübers

Published in: European journal of neurology (2020)

We report three cases of typical GBS (AIDP) occurring after SARS-CoV-2 infection and presenting with a favourable clinical course. Given the interval between COVID-19-related symptoms and neurological manifestations (mean of 15 days) we postulate a secondary immune-mediated mechanism rather than direct viral damage.

Keyphrases

sars cov
respiratory syndrome coronavirus
case report
oxidative stress
coronavirus disease
physical activity
depressive symptoms
cerebral ischemia
blood brain barrier